Premium
Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions
Author(s) -
Movila Alexandru,
Ishii Takenobu,
Albassam Abdullah,
Wisitrasameewong Wichaya,
Howait Mohammed,
Yamaguchi Tsuguno,
RuizTorruella Montserrat,
Bahammam Laila,
Nishimura Kazuaki,
Van Dyke Thomas,
Kawai Toshihisa
Publication year - 2016
Publication title -
journal of bone and mineral research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.882
H-Index - 241
eISSN - 1523-4681
pISSN - 0884-0431
DOI - 10.1002/jbmr.2854
Subject(s) - osteoclast , macrophage migration inhibitory factor , osteolysis , bone resorption , chemistry , chemokine , chemokine receptor , calvaria , cxc chemokine receptors , stromal cell , microbiology and biotechnology , rankl , receptor , cytokine , cancer research , endocrinology , in vitro , immunology , biology , medicine , biochemistry , activator (genetics) , surgery
ABSTRACT By binding to its chemokine receptor CXCR4 on osteoclast precursor cells (OCPs), it is well known that stromal cell‐derived factor‐1 (SDF‐1) promotes the chemotactic recruitment of circulating OCPs to the homeostatic bone remodeling site. However, the engagement of circulating OCPs in pathogenic bone resorption remains to be elucidated. The present study investigated a possible chemoattractant role of macrophage migration inhibitory factor (MIF), another ligand for C‐X‐C chemokine receptor type 4 (CXCR4), in the recruitment of circulating OCPs to the bone lytic lesion. To accomplish this, we used Csf1r‐eGFP‐knock‐in (KI) mice to establish an animal model of polymethylmethacrylate (PMMA) particle‐induced calvarial osteolysis. In the circulating Csf1r‐eGFP+ cells of healthy Csf1r‐eGFP‐KI mice, Csf1r+/CD11b+ cells showed a greater degree of RANKL‐induced osteoclastogenesis compared to a subset of Csf1r+/RANK+ cells in vitro. Therefore, Csf1r‐eGFP+/CD11b+ cells were targeted as functionally relevant OCPs in the present study. Although expression of the two cognate receptors for MIF, CXCR2 and CXCR4, was elevated on Csf1r+/CD11b+ cells, transmigration of OCPs toward recombinant MIF in vitro was facilitated by ligation with CXCR4, but not CXCR2. Meanwhile, the level of PMMA‐induced bone resorption in calvaria was markedly greater in wild‐type (WT) mice compared to that detected in MIF‐knockout (KO) mice. Interestingly, in contrast to the elevated MIF, diminished SDF‐1 was detected in a particle‐induced bone lytic lesion of WT mice in conjunction with an increased number of infiltrating CXCR4+ OCPs. However, such diminished SDF‐1 was not found in the PMMA‐injected calvaria of MIF‐KO mice. Furthermore, stimulation of osteoblasts with MIF in vitro suppressed their production of SDF‐1, suggesting that MIF can downmodulate SDF‐1 production in bone tissue. Systemically administered anti‐MIF neutralizing monoclonal antibody (mAb) inhibited the homing of CXCR4+ OCPs, as well as bone resorption, in the PMMA‐injected calvaria, while increasing locally produced SDF‐1. Collectively, these data suggest that locally produced MIF in the inflammatory bone lytic site is engaged in the chemoattraction of circulating CXCR4+ OCPs. © 2016 American Society for Bone and Mineral Research.